Current clinical studies confirm that the consumption of oats for people suffering from celiac disease is safe. Some studies have confirmed different levels of immunoreactive gluten epitopes of oats in different cultivars, while others explain these differences due to contamination with gluten-rich species or as random cross-reactivity ELISA of homologous oat epitopes with anti-wheat gliadin antibodies. The aim of our two-year study was therefore to map cross-reactive oat epitopes in a set of 132 oat cultivars using a G12-based ELISA kit. The results were focused on the varietal and annual level of cross-reactivity (interference) of avenin epitopes with the G12 antibody on the identification of potential cultivars with significantly different interferences and assessing the degree of risk of possible false-contamination with external gluten. Although repeated evaluations confirmed high year-to-year variability (RSD ≥ 30%) in approximately 2/3 of the cultivars, the content of interfering avenin epitopes with G12 did not exceed the considered safe limit (20 mg·kg-1) for celiacs. At the same time, not only annual but, above all, significant cultivar dependences in the interference of avenins to the G12 antibody were demonstrated. Genetic dependence was further confirmed in connection with the proven avenin polymorphism as well as immunoblotting with the identification of interfering peptides with the G12 antibody in the 25 and 30 kDa regions. It was the occurrence of two bands around 30 kDa that predominantly occurred in oat cultivars with a relatively higher content of cross-reactive avenins (12-16 mg·kg-1). Due to the fact that the contents of interfering avenins ranged in several cultivars even over 16 mg·kg-1, the choice of a suitable oat cultivar may be crucial for gluten-free food producers, as it reduces the risk of a possible false-response of the commercial ELISA kits when checking the real-gluten contamination.

Crop Research Institute Drnovská 507 73 16106 Prague Czech Republic

Zobrazit více v PubMed

Gorash A., Armonienė R., Fetch J.M., Liatukas Ž., Danytė V. Aspects in oat breeding: Nutrition quality, nakedness and disease resistance, challenges and perspectives. Ann. Appl. Biol. 2017;171:281–302. doi: 10.1111/aab.12375. DOI

Ahmad A., Anjum F.M., Zahoor T., Nawaz H., Ahmed Z. Extraction and characterization of β-d-glucan from oat for industrial utilization. Int. J. Biol. Macromol. 2010;46:304–309. doi: 10.1016/j.ijbiomac.2010.01.002. PubMed DOI

Jágr M., Dvořáček V., Čepková P.H., Doležalová J. Comprehensive analysis of oat avenanthramides using hybrid quadrupole-Orbitrap mass spectrometry: Possible detection of new compounds. Rapid Commun. Mass Spectrom. 2020;34:e8718. doi: 10.1002/rcm.8718. PubMed DOI

Fritz R.D., Chen Y. Oat safety for celiac disease patients: Theoretical analysis correlates adverse symptoms in clinical studies to contaminated study oats. Nutr. Res. 2018;60:54–67. doi: 10.1016/j.nutres.2018.09.003. PubMed DOI

Pinto-Sánchez M.I., Causada-Calo N., Bercik P., Ford A., Murray J.A., Armstrong D., Semrad C., Kupfer S.S., Alaedini A., Moayyedi P., et al. Safety of Adding Oats to a Gluten-Free Diet for Patients with Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. Gastroenterology. 2017;153:395–409.e3. doi: 10.1053/j.gastro.2017.04.009. PubMed DOI

Barcchiya J., Meena R.K., Lal N. Oat is a multifunctional cereal crop. Innov. Farming. 2017;2:114–116.

Gilissen L.J., Van Der Meer I.M., Smulders M.J.M. Why Oats Are Safe and Healthy for Celiac Disease Patients. Med. Sci. 2016;4:21. doi: 10.3390/medsci4040021. PubMed DOI PMC

Real A., Comino I., de Lorenzo L., Merchán F., Gil-Humanes J., Giménez M.J., Barro F. Molecular and immunological characterization of gluten proteins isolated from oat cultivars that differ in toxicity for celiac disease. PLoS ONE. 2012;7:e48365. doi: 10.1371/journal.pone.0048365. PubMed DOI PMC

Comino Montilla I.M., Lorenzo Barrios L.D., Cornell H., López Casado M.Á., Barro F., Sousa Martín C. Diversity in oat potential immunogenicity: Basis for the selection of oat varieties with no toxicity in coeliac disease. Gut. 2011;60:915–922. doi: 10.1136/gut.2010.225268. PubMed DOI PMC

Ballabio C., Uberti F., Manferdelli S., Vacca E., Boggini G., Redaelli R., Restani P. Molecular characterisation of 36 oat varieties and in vitro assessment of their suitability for coeliacs’ diet. J. Cereal Sci. 2011;54:110–115. doi: 10.1016/j.jcs.2011.04.004. DOI

Londono D., Westende W.V., Goryunova S., Salentijn E., Broeck H.V.D., van der Meer I., Visser R., Gilissen L., Smulders M. Avenin diversity analysis of the genus Avena (oat). Relevance for people with celiac disease. J. Cereal Sci. 2013;58:170–177. doi: 10.1016/j.jcs.2013.03.017. DOI

Lexhaller B., Tompos C., Scherf K.A. Comparative analysis of prolamin and glutelin fractions from wheat, rye, and barley with five sandwich ELISA test kits. Anal. Bioanal. Chem. 2016;408:6093–6104. doi: 10.1007/s00216-016-9721-7. PubMed DOI

Huang X., Kanerva P., Salovaara H., Stoddard F.L., Sontag-Strohm T. Proposal for C-Hordein as Reference Material in Gluten Quantification. J. Agric. Food Chem. 2017;65:2155–2161. doi: 10.1021/acs.jafc.6b05061. PubMed DOI

Tanner G.J., Blundell M.J., Colgrave M.L., Howitt C.A. Quantification of Hordeins by ELISA: The Correct Standard Makes a Magnitude of Difference. PLoS ONE. 2013;8:e56456. doi: 10.1371/journal.pone.0056456. PubMed DOI PMC

Wehling P., Scherf K.A. Preparation of validation materials for estimating gluten recovery by ELISA according to SMPR 2017.021. J. AOAC Int. 2020;103:210–215. doi: 10.5740/jaoacint.19-0081. PubMed DOI

Sollid L.M., Qiao S.-W., Anderson R.P., Gianfrani C., Koning F. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics. 2012;64:455–460. doi: 10.1007/s00251-012-0599-z. PubMed DOI PMC

Kosová K., Leišová-Svobodová L., Dvořáček V. Oats as a Safe Alternative to Triticeae Cereals for People Suffering from Celiac Disease? A Review. Plant Foods Hum. Nutr. 2020;75:131–141. doi: 10.1007/s11130-020-00800-8. PubMed DOI

Mujico J.R., Mitea C., Gilissen L.J., de Ru A., van Veelen P., Smulders M.J., Koning F. Natural variation in avenin epitopes among oat varieties: Implications for celiac disease. J. Cereal Sci. 2011;54:8–12. doi: 10.1016/j.jcs.2010.09.007. DOI

Ahola H.G., Sontag-Strohm T.S., Schulman A.H., Tanhuanpää P., Viitala S., Huang X. Immunochemical analysis of oat avenins in an oat cultivar and landrace collection. J. Cereal Sci. 2020;95:103053. doi: 10.1016/j.jcs.2020.103053. DOI

Halbmayr-Jech E., Hammer E., Fielder R., Coutts J., Rogers A., Cornish M. Characterization of G12 sandwich ELISA, a next-generation immunoassay for gluten toxicity. J. AOAC Int. 2012;95:372–376. doi: 10.5740/jaoacint.SGE_Halbmayr-Jech. PubMed DOI

Tanner G., Juhasz A., Florides C.G., Nye-Wood M., Békés F., Colgrave M.L., Russell A.K., Hardy M., Tye-Din J.A. Preparation and Characterization of Avenin-Enriched Oat Protein by Chill Precipitation for Feeding Trials in Celiac Disease. Front. Nutr. 2019;6:162. doi: 10.3389/fnut.2019.00162. PubMed DOI PMC

Laemmli U.K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. PubMed DOI

Gojković-Cvjetković V.S., Grujić R.D., Marjanović-Balaban R., Stanojević L.P., Stanojević J.S., Cakić M.D. Gliadin analysis by reversed-phase high performance liquid chromatography. Adv. Technol. 2019;8:30–36. doi: 10.5937/savteh1902030G. DOI

NO, E.R. 41/2009. Commission Regulation Concerning the Composition and Labelling of Foodstuffs Suitable for People Intolerant to Gluten. [(accessed on 23 October 2021)]. Available online: https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%3A32009R0041.

Marín-Sanz M., Giménez M.J., Barro F., Savin R. Prolamin Content and Grain Weight in RNAi Silenced Wheat Lines under Different Conditions of Temperature and Nitrogen Availability. Front. Plant Sci. 2020;11:314. doi: 10.3389/fpls.2020.00314. PubMed DOI PMC

Shewry P.R., Halford N.G. Cereal seed storage proteins: Structures, properties and role in grain utilization. J. Exp. Bot. 2002;53:947–958. doi: 10.1093/jexbot/53.370.947. PubMed DOI

Gregová E., Šliková S., Hozlár P. Seed protein electrophoresis for identification of oat registered cultivars. Potravin. Slovak J. Food Sci. 2015;9:411–416. doi: 10.5219/513. DOI

Wieser H. Chemistry of gluten proteins. Food Microbiol. 2007;24:115–119. doi: 10.1016/j.fm.2006.07.004. PubMed DOI

Balakireva A.V., Zamyatnin A.A. Properties of Gluten Intolerance: Gluten Structure, Evolution, Pathogenicity and Detoxification Capabilities. Nutrients. 2016;8:644. doi: 10.3390/nu8100644. PubMed DOI PMC

Comino I., Bernardo D., Bancel E., Moreno M.D.L., Sánchez B., Barro F., Šuligoj T., Ciclitira P.J., Cebolla A., Knight S.C., et al. Identification and molecular characterization of oat peptides implicated on coeliac immune response. Food Nutr. Res. 2016;60:30324. doi: 10.3402/fnr.v60.30324. PubMed DOI PMC

Gimenez M.J., Real A., García-Molina M.D., Sousa C., Barro F. Characterization of celiac disease related oat proteins: Bases for the development of high quality oat varieties suitable for celiac patients. Sci. Rep. 2017;7:42588. doi: 10.1038/srep42588. PubMed DOI PMC

Panda R., Zoerb H.F., Cho C., Jackson L.S., Garber E.A. Detection and Quantification of Gluten during the Brewing and Fermentation of Beer Using Antibody-Based Technologies. J. Food Prot. 2015;78:1167–1177. doi: 10.4315/0362-028X.JFP-14-546. PubMed DOI

Sajic N., Oplatowska-Stachowiak M., Streppel L., Drijfhout J.-W., Salden M., Koning F. Development and in-house validation of a competitive ELISA for the quantitative detection of gluten in food. Food Control. 2017;80:401–410. doi: 10.1016/j.foodcont.2017.05.021. DOI

Alves T.O., D’Almeida C.T., Scherf K.A., Ferreira M.S. Modern approaches in the identification and quanti-fication of immunogenic peptides in cereals by LC-MS/MS. Front. Plant Sci. 2019;10:1470. doi: 10.3389/fpls.2019.01470. PubMed DOI PMC